Literature DB >> 28467684

Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.

Li Wang1, Katarzyna Kazmierczak2, Chen-Ching Yuan2, Sunil Yadav2, Masataka Kawai1, Danuta Szczesna-Cordary2.   

Abstract

We have investigated the physiology and mechanical profiles of skinned papillary muscle fibers from transgenic mice expressing the N47K mutation in the myosin regulatory light chain (RLC), shown to cause hypertrophic cardiomyopathy in humans. The results were compared with wild-type (WT) mice, both expressing the human ventricular RLC. Rate constants of a cross-bridge (XB) cycle were deduced from tension transients induced by sinusoidal length changes during maximal Ca2+ activation, and were studied as a function of MgATP, MgADP, and Pi concentrations. N47K mutant showed slower XB cycles but higher actin-activated ATPase activity compared with WT. Consequently, N47K exhibited larger tension than WT. K0 (ADP association constant) and K4 (equilibrium constant of force generation) were larger in N47K, and K1 (ATP association constant) was slightly larger in N47K vs. WT, demonstrating stronger nucleotide binding and force generation abilities of the mutant, but no changes in rigor acto-myosin binding were observed. Tension per XB was similar among groups, but N47K exhibited more XB distribution in the attached state. Larger values of tension and higher ATPase in N47K suggested that more cross-bridges participated in tension production in the mutant myocardium compared with WT. In vivo analysis of heart function, performed in ~ 12.5-month-old mice by echocardiography and invasive hemodynamics, demonstrated a significant decrease in dP/dtmax -end-diastolic volume relationship, indicating a depression of ventricular contractility in N47K mice. Our findings suggest that the N47K mutation exerts its action through direct alterations of myosin motor function that ultimately result in pathological hypertrophic remodeling in N47K hearts.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  N47K-mouse model; cardiac contractility; cardiomyopathy; cross-bridge cycle; elementary steps; myosin regulatory light chain; sinusoidal analysis

Mesh:

Substances:

Year:  2017        PMID: 28467684      PMCID: PMC5490660          DOI: 10.1111/febs.14096

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  49 in total

1.  Cross-bridge kinetics in rat myocardium: effect of sarcomere length and calcium activation.

Authors:  T Wannenburg; G H Heijne; J H Geerdink; H W Van Den Dool; P M Janssen; P P De Tombe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-08       Impact factor: 4.733

Review 2.  Mechanism of actomyosin ATPase and the problem of muscle contraction.

Authors:  E W Taylor
Journal:  CRC Crit Rev Biochem       Date:  1979

3.  Hemodynamic determinants of the time-course of fall in canine left ventricular pressure.

Authors:  J L Weiss; J W Frederiksen; M L Weisfeldt
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

4.  Correlation between myofilament response to Ca2+ and altered dynamics of contraction and relaxation in transgenic cardiac cells that express beta-tropomyosin.

Authors:  B M Wolska; R S Keller; C C Evans; K A Palmiter; R M Phillips; M Muthuchamy; J Oehlenschlager; D F Wieczorek; P P de Tombe; R J Solaro
Journal:  Circ Res       Date:  1999-04-16       Impact factor: 17.367

5.  Pyrene actin: documentation of the validity of a sensitive assay for actin polymerization.

Authors:  J A Cooper; S B Walker; T D Pollard
Journal:  J Muscle Res Cell Motil       Date:  1983-04       Impact factor: 2.698

6.  Head rotation or dissociation? A study of exponential rate processes in chemically skinned rabbit muscle fibers when MgATP concentration is changed.

Authors:  M Kawai
Journal:  Biophys J       Date:  1978-04       Impact factor: 4.033

7.  Two step mechanism of phosphate release and the mechanism of force generation in chemically skinned fibers of rabbit psoas muscle.

Authors:  M Kawai; H R Halvorson
Journal:  Biophys J       Date:  1991-02       Impact factor: 4.033

8.  Myosin regulatory light chain phosphorylation enhances cardiac β-myosin in vitro motility under load.

Authors:  Anastasia Karabina; Katarzyna Kazmierczak; Danuta Szczesna-Cordary; Jeffrey R Moore
Journal:  Arch Biochem Biophys       Date:  2015-06-25       Impact factor: 4.013

9.  Three-dimensional structure of myosin subfragment-1: a molecular motor.

Authors:  I Rayment; W R Rypniewski; K Schmidt-Bäse; R Smith; D R Tomchick; M M Benning; D A Winkelmann; G Wesenberg; H M Holden
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

10.  Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro.

Authors:  Edward P Debold; Walid Saber; Yaser Cheema; Carol S Bookwalter; Kathleen M Trybus; David M Warshaw; Peter Vanburen
Journal:  J Mol Cell Cardiol       Date:  2009-09-30       Impact factor: 5.000

View more
  3 in total

Review 1.  Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.

Authors:  Sunil Yadav; Yoel H Sitbon; Katarzyna Kazmierczak; Danuta Szczesna-Cordary
Journal:  Pflugers Arch       Date:  2019-01-31       Impact factor: 3.657

2.  Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca2+ sensitivity.

Authors:  Jiajia Zhang; Li Wang; Katarzyna Kazmierczak; Hang Yun; Danuta Szczesna-Cordary; Masataka Kawai
Journal:  FEBS J       Date:  2021-03-10       Impact factor: 5.542

3.  Mavacamten decreases maximal force and Ca2+ sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy.

Authors:  Peter O Awinda; Marissa Watanabe; Yemeserach Bishaw; Anna M Huckabee; Keinan B Agonias; Katarzyna Kazmierczak; Danuta Szczesna-Cordary; Bertrand C W Tanner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-18       Impact factor: 4.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.